Cortisol controlled release by mesoporous silica

被引：23

作者：

Lopez, Tessy ^{[1
,2
]}

Ortiz, Emma ^{[2
]}

Alexander-Katz, Roberto ^{[3
]}

Basaldella, Elena ^{[4
]}

Bokhimi, Xim ^{[5
]}

机构：

[1] Univ Autonoma Metropolitana Xochimilco, Dept Atenc Salud, Mexico City, DF, Mexico

[2] Inst Nacl Neurol & Neurocirugia MVS, Mexico City, DF, Mexico

[3] Univ Autonoma Metropolitana Iztapalapa, Dept Fis, Mexico City, DF, Mexico

[4] Univ Nacl La Plata, CIC, CINDECA, La Plata, Buenos Aires, Argentina

[5] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 01000, DF, Mexico

来源：

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 2009年 / 5卷 / 02期

关键词：

Hydrocortisone; Mesoporous; Ordered silicas; Drug release; Sol-gel; DRUG-DELIVERY; NEURODEGENERATIVE DISEASES; VALPROIC ACID; TEMPORAL-LOBE; TITANIA; SYSTEM; PHENYTOIN; SOLIDS; BRAIN; MICROPARTICLES;

D O I：

10.1016/j.nano.2008.08.002

中图分类号：

TB3 [工程材料学];

学科分类号：

0805 ; 080502 ;

摘要：

In this study four types of SBAs were synthesized and then impregnated with hydrocortisone. One is a straight SBA-15, obtained using Pluronics P123 as structuring agent; two others were modified using 1,3,5-trimethylbenzene as additive, and the fourth one was prepared using sodium iodide as additive. Three of these have in common a p6mm symmetry with nanotubes packed hexagonally, yet they differ in their functional groups. The fourth sample is basically disordered. The drug release kinetics showed two stages: a fast-rate early stage dominated by the controlled release of the hydrocortisone adsorbed in the macropores of the reservoir, followed by a slow-rate delivery that we assume is controlled by the hydrocortisone diffusion through the nanopores. It is shown that the release kinetics can be strongly influenced by using different co-additives. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：170 / 177

页数：8

共 30 条

[11] The determination of dielectric constants of mixtures used in the treatment of epilepsy and the encapsulation of phenytoin in a titania matrix [J].

Lopez, T. ;

Quintana, P. ;

Ascencio, J. ;

Gonzalez, R. D. .

COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2007, 300 (1-2) :99-105

[12] A nanostructured titania bioceramic implantable device capable of drug delivery to the temporal lobe of the brain [J].

Lopez, T. ;

Ortiz, E. ;

Quintana, P. ;

Gonzalez, R. D. .

COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2007, 300 (1-2) :3-10

[13] Characterization of sodium phenytoin co-gelled with titania for a controlled drug-release system [J].

Lopez, T. ;

Quintana, P. ;

Ortiz-Islas, E. ;

Vinogradova, E. ;

Manjarrez, J. ;

Aguilar, D. H. ;

Castillo-Ocampo, P. ;

Magana, C. ;

Azamar, J. A. .

MATERIALS CHARACTERIZATION, 2007, 58 (8-9) :823-828

[14] Biocompatible titania microtubes formed by nanoparticles and its application in the drug delivery of valproic acid [J].

Lopez, T. ;

Ortiz-Islas, E. ;

Manjarrez, J. ;

Rodriguez Reinoso, F. ;

Sepulveda, A. ;

Gonzalez, R. D. .

OPTICAL MATERIALS, 2006, 29 (01) :70-74

[15] Encapsulation of valproic acid and sodic phenytoin in ordered mesoporous SiO2 solids for the treatment of temporal lobe epilepsy [J].

Lopez, T. ;

Basaldella, E. I. ;

Ojeda, M. L. ;

Manjarrez, J. ;

Alexander-Katz, R. .

OPTICAL MATERIALS, 2006, 29 (01) :75-81

[16] Synthesis of TiO2 nanostructured reservoir with temozolomide:: Structural evolution of the occluded drug [J].

Lopez, T. ;

Sotelo, J. ;

Navarrete, J. ;

Ascencio, J. A. .

OPTICAL MATERIALS, 2006, 29 (01) :88-94

[17] An implantable sol-gel derived titania-silica carrier system for the controlled release of anticonvulsants [J].

Lopez, T. ;

Manjarrez, J. ;

Rembao, D. ;

Vinogradova, E. ;

Moreno, A. ;

Gonzalez, R. D. .

MATERIALS LETTERS, 2006, 60 (23) :2903-2908

[18]

López T, 2009, KEY ENG MATER, V391, P169, DOI 10.4028/www.scientific.net/KEM.391.169

[19]

LOPEZ T, 2008, ACTA BIOMAT IN PRESS

[20] Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases [J].

Mannila, A ;

Rautio, J ;

Lehtonen, M ;

Järvinen, T ;

Savolainen, J .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (01) :101-105

← 1 2 3 →